References
- Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. eds. AJCC cancer staging manual. 7th ed. New York: Springer Science and Business Media; 2010.
- Meskawi M, Sun M, Tinh QD, Bianchi M, Hansen J, Tian Z, et al. A review of integrated staging systems for renal cell carcinoma. Eur Urol 2012;62:303–14.
- Jorns J, Thiel DD, Lohse CM, Williams A, Arnold ML, Cheville JC, et al. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma. BJU Int 2012;110:956–60.
- Feldman JP, Goldwasser R, Mark S, Schwartz J, Orion I. A mathematical model for tumor volume evaluation using two-dimensions. J Appl Quant Methods 2009;4:455–62.
- Seçil M, Çullu N, Aslan G, Mungan U, Uysal F, Tuna B, et al. The effect of tumor volume on survival in patients with renal cell carcinoma. Diagn Interv Radiol 2012;18:480–7.
- Jilg CA, Neumann HP, Gläsker S, Schäfer O, Ardelt PU, Schwardt M, et al. Growth kinetics in Von Hippel–Lindau-associated renal cell carcinoma. Urol Int 2012;88:71–8.
- Smaldone MC, Kutikov A, Egleston BL, Canter DJ, Viterbo R, Chen DY, et al. Small renal masses progressing to metastases under active surveillance. Cancer 2012;118:997–1006.
- Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001;166:63–7.
- Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, et al. Prediction of progression after radical nephrectomy of patients with clear cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003;97:1663–7.
- Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 2002;168:2395–400.